comprehensive -WSS

comprehensive

author：leisure time 2025-10-02 23:30:57 - browse：9674

A liver with a smooth and healthy left half and a bumpy, browning right half — chronic disease coverage from STAT — Adobe

Akero Therapeutics said Monday that extending treatment with its experimental drug for the liver disease known as MASH from six months to two years resulted in better outcomes for patients — most notably reductions in liver scarring at a rate three times higher than placebo without worsening other symptoms.

The mid-stage study of the Akero drug called efruxifermin achieved its main goal in September 2022. With longer treatment, more patients with MASH responded to the drug, while those who initially benefited showed durable improvements.

“We’re really pleased with the data. It’s exactly what we were hoping to see,” said Kitty Yale, Akero’s chief development officer, in an interview with STAT. “It’s not just the high response rates, but the fact that responses are sustained and broadened as well.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： What causes osteoarthritis? Researchers study link to brain protein

knowledge

entertainment

WSS

AbbVie dramatically boosts its spending on lobbying

Update the Apgar Score to remove skin color

HIPAA doesn't protect reproductive records from prosecutors

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Why an extreme heat and wildfire smoke combination can be so dangerous

Medicare drug price lawsuits could be good politics for Biden

hotspot

comprehensive

leisure time

Apple is now the first public company to be valued at $3 trillion

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Medicare details structure of new drug price negotiation program

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Moonlake's readout produced a cash windfall. Risks remain

To bolster infectious disease surveillance, genomics powerhouses team up

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Apple is now the first public company to be valued at $3 trillion

CDC backtracks, saying fully vaccinated people can go maskless indoors

leisure time

Elizabeth Warren probes abortion access

FDA endorses new sterilization method for medical devices

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

What causes osteoarthritis? Researchers study link to brain protein

Inaction leaves children at risk from dangerous chemotherapy drug

Body of missing toddler recovered in Delaware River days after flood: Police

knowledge

entertainment

Wikipedia

explore